Collectively, ARID1A loss reportedly promotes mutagenicity of the tumor and may induce a similar phenotype to that of POLE-mutated or MMR-deficient tumors, that may play a key role in endometrial carcinogenesis. This evidence concerns the gene ARID1A and neoplasm.